Matilda is part of the business consulting team, supporting biotech and large multinational pharma clients in strategy projects across the EU, U.S. and China markets.
Matilda has experience with a wide range of global projects across the entire product life cycle (pipeline, launch, and in-line brands) working with cross functional teams (commercial, medical and market access).
Her areas of project expertise include portfolio and disease area strategy, opportunity assessments, go-to-market strategy and launch planning, market access and brand strategy planning. Her areas of therapeutic expertise include molecular diagnostics, oncology, rare diseases and infectious diseases.
Matilda holds a Ph.D. in genome biology from EMBL (European Molecular Biology Laboratory) and an MSc in molecular biosciences from the University of Heidelberg, Germany. Matilda is a native Croatian speaker, bilingual in English and fluent in German.